Can you use the last bit of Mounjaro in the pen?

The myth: residual liquid means a wasted dose

People come to this question from a very understandable place. Mounjaro is not cheap, and when you hold a pen up to the light after the fourth click and see a tiny pool of liquid still sitting there, it is easy to assume you have been short-measured. That assumption is wrong, and gently letting it go matters, because acting on it could cause problems.

Pharmaceutical manufacturers are required to overfill pre-filled injection devices by a small margin. This ensures that when the plunger mechanism delivers dose four, enough pressure is behind it to push a complete, accurate volume through the needle. The leftover fluid is what makes doses one through four reliable, not a bonus fifth injection waiting to be claimed. Eli Lilly builds this into every Mounjaro KwikPen by design, and the Mounjaro SmPC on the electronic Medicines Compendium makes clear that the pen is intended for four injections only.

Practically speaking, even if you tilted the pen, applied extra pressure, or tried to aspirate the remainder with an additional needle, you would have no way of knowing how much liquid you had actually delivered. That uncertainty matters on a medicine that is titrated carefully by a prescriber over weeks. A miscalculated dose (whether too little or too little arrived in the previous injection) can affect how your next titration decision is made.

What the pen's lock mechanism is actually telling you

After the fourth dose, the KwikPen locks. The dose button will not depress further. Some patients assume this is a defect. It is not. The lock is a deliberate safety feature that prevents re-use of a single-patient device and signals clearly that the pen has reached the end of its designed function.

The NHS tirzepatide information page advises patients to read the instructions for use carefully and to dispose of used pens safely, each pen is for one person only and should go into a sharps bin after its four doses are complete. If the pen locked before what felt like a full fourth dose, that is a different matter and worth reporting to your pharmacy promptly, rather than improvising with the device.

Storage affects delivery too. A pen that has been left at room temperature beyond the permitted window, or that has been frozen accidentally, may not perform exactly as expected. If you have concerns about a specific injection, your prescriber is the right person to speak to before the next one, and our guidance on whether a Mounjaro pen can be used after 30 days is worth reading if storage timing is part of your concern. Questions about ongoing treatment, including whether a dose may have been incomplete, are part of what clinical aftercare is for.

Handling, disposal and what a short injection actually looks like

A common separate concern is the feeling that an injection finished too quickly, or that the pen made an unexpected sound. Mounjaro pens deliver medicine subcutaneously over a few seconds; technique can affect confidence in the result. The needle should remain in the skin for at least ten seconds after the dose button is fully pressed, and the button should be held down throughout. If the yellow indicator in the viewing window has moved to show the dose was complete, the injection has been delivered as designed.

Used pens should be disposed of in a purpose-made sharps container rather than a household bin or recycling. If you do not have one, your pharmacy can advise on sharps disposal in your area.

If you are uncertain about what good technique looks like, or whether your pen behaved normally, the patient information leaflet included in the box covers the full step-by-step process. For questions specific to your dose or treatment history, the team at our contact page can direct you to the right prescriber. And if you are currently exploring whether Mounjaro is the right option for you at all, our page covering who can use Mounjaro and whether it suits your situation sets out the full clinical picture.

When to flag a pen issue, and to whom

There are a few genuine scenarios worth raising rather than ignoring. If the pen felt like it stopped mid-dose, if the yellow indicator only partially moved, or if the pen felt unusual in any way during the injection, log it and contact your prescriber before the next scheduled dose. Do not try to compensate by adjusting timing or quantity yourself, titration decisions sit with the clinician, not the patient.

If you are also thinking about costs as your treatment progresses, our Mounjaro cost context page explains what drives UK pricing and what a transparent private prescription covers, so there are no surprises. Those thinking about how long a course might run can also read about whether a single month of Mounjaro is a realistic starting point.

Suspected faults with any pen (not just a feeling of residual liquid, but anything that suggests the device did not function correctly) can be reported to the MHRA via the Yellow Card scheme, which covers both medicines and medical devices. It is worth doing; those reports inform regulatory oversight of the product. If you are also managing digestive discomfort during treatment, our page on taking Gaviscon alongside Mounjaro addresses a question that comes up regularly and is worth a read.

For anyone not yet on treatment and thinking about whether to start, our page on whether you can use Mounjaro is a helpful first step before you check your eligibility with our prescribers, the consultation is free, and a real clinician reads your answers the same day.